FDA Hits Aesica Over Quality Controls, Record-Keeping Post author:Sam Post published:April 19, 2017 Post category:Drug Industry Daily The FDA has cited contract manufacturer Aesica for quality and record-keeping problems. Source: Drug Industry Daily You Might Also Like Advisory Committee Endorses Pfizer’s RSV Vaccine Candidate February 28, 2023 FDA to Revise 20-Year-Old ICH Reproductive Risks Guideline November 9, 2017 Gottlieb Calls for Expansion of FDA Authorities to Fight IV Drug Shortages May 31, 2018